Free Trial
NYSE:RBOT

Vicarious Surgical (RBOT) Stock Price, News & Analysis

Vicarious Surgical logo
$0.70 +0.01 (+1.45%)
As of 05/14/2026 03:57 PM Eastern

About Vicarious Surgical Stock (NYSE:RBOT)

Advanced

Key Stats

Today's Range
$0.64
$0.75
50-Day Range
$0.42
$1.20
52-Week Range
$0.27
$13.75
Volume
26,193 shs
Average Volume
81,928 shs
Market Capitalization
$4.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Reduce

Company Overview

Vicarious Surgical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
32nd Percentile Overall Score

RBOT MarketRank™: 

Vicarious Surgical scored higher than 32% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vicarious Surgical has received a consensus rating of Reduce. The company's average rating score is 1.67, and is based on no strong buy ratings, no buy ratings, 2 hold ratings, and 1 sell rating.

  • Upside Potential

    Vicarious Surgical has a consensus price target of $7.00, representing about 900.0% upside from its current price of $0.70.

  • Amount of Analyst Coverage

    Vicarious Surgical has received no research coverage in the past 90 days.

  • Read more about Vicarious Surgical's stock forecast and price target.
  • Earnings Growth

    Earnings for Vicarious Surgical are expected to grow in the coming year, from ($10.89) to ($8.50) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vicarious Surgical is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vicarious Surgical is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Vicarious Surgical has a P/B Ratio of 0.09. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Vicarious Surgical's valuation and earnings.
  • Short Interest

    There is no current short interest data available for RBOT.
  • Dividend Yield

    Vicarious Surgical does not currently pay a dividend.

  • Dividend Growth

    Vicarious Surgical does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Vicarious Surgical this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Vicarious Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,537.00 in company stock.

  • Percentage Held by Insiders

    9.46% of the stock of Vicarious Surgical is held by insiders.

  • Percentage Held by Institutions

    47.27% of the stock of Vicarious Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Vicarious Surgical's insider trading history.
Receive RBOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicarious Surgical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RBOT Stock News Headlines

$30 stock to buy before Starlink goes public (WATCH NOW!)
A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.tc pixel
Vicarious Surgical, Inc. Class A
See More Headlines

RBOT Stock Analysis - Frequently Asked Questions

Vicarious Surgical's stock was trading at $2.16 at the beginning of the year. Since then, RBOT stock has decreased by 67.6% and is now trading at $0.70.

Vicarious Surgical Inc. (NYSE:RBOT) released its quarterly earnings data on Monday, March, 9th. The company reported ($1.65) earnings per share for the quarter, missing the consensus estimate of ($1.37) by $0.28.

Shares of Vicarious Surgical reverse split on Thursday, June 13th 2024.The 1-30 reverse split was announced on Thursday, June 13th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 13th 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of RBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vicarious Surgical investors own include NVIDIA (NVDA), Aktis Oncology (AKTS), Advanced Micro Devices (AMD), PayPal (PYPL), Taiwan Semiconductor Manufacturing (TSM) and SoFi Technologies (SOFI).

Company Calendar

Last Earnings
3/09/2026
Today
5/15/2026
Next Earnings (Estimated)
7/30/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NYSE:RBOT
CIK
1812173
Fax
N/A
Employees
210
Year Founded
2014

Price Target and Rating

High Price Target
$7.00
Low Price Target
$7.00
Potential Upside/Downside
+900.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($6.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.22 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-184.13%
Return on Assets
-112.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.75
Quick Ratio
4.75

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.89 per share
Price / Book
0.09

Miscellaneous

Outstanding Shares
7,122,000
Free Float
5,894,000
Market Cap
$4.99 million
Optionable
No Data
Beta
1.49

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NYSE:RBOT) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners